Nanalysis Scientific Corp · TSXV:NSCI
Nanalysis Scientific — Investor Presentation (May 2026)
18 slides from Nanalysis Scientific's investor presentation, May 2026
Slide 1: Portable MRI for Industrial Applications
Portable MRI for industrial applications TSXV: NSCI | PINK: NSCIF | Frankfurt: 1N1 Imaging & Detection Products & Services Industrial & Healthcare Applications Sean Krakiwsky, CEO May 2026 “We are building a global scientific instrumentation company with proprietary magnetic resonance products as ou
Slide 2: Disclaimers
Disclaimers Information contained in this document has been prepared by Nanalysis Scientific Corp . ("Nanalysis " or the " Company ") and contains information pertaining to the business, operations, and assets of the Company . The information contained in this document (a) is provided as at the date
Slide 3: Why invest in us?
Why invest in us? 1. Category -creating global technology company: Compelling Investment Portable MRI Machines for Industrial Applications 2. $40MM TTM revenue (EBITDA + ive) 3. Product Sales + Recuring Service Revenue “Our Mission is to improve the quality and safety of our customers’ products, wit
Slide 4: Stock/Valuation Comparables
Stock/Valuation Comparables Multiples for Instrumentation Agilent Technologies Perkin Elmer Companies * (average, large cap) AMETEK Sartorius AG ○ P/E: 28 Bruker Corporation Shimadzu Danaher Teledyne ○ EV / EBITDA: 23 Mettler -Toledo Thermo Fisher Scientific ○ EV / TTM Sales: 4 Oxford Instruments Wa
Slide 5: Market Opportunity
Market Opportunity Scientific Instrumentation market over $75B per year* Gov. Growth Drivers Testing 3% ○ Miniaturization is making equipment standard Other Academia Chemicals 16% 17% ○ New i ndustry -specific applications 4% ○ Cloud and AI is creating opportunities for General & Pharma personalized
Slide 6: Sales Organization
Sales Organization United States, Europe, Canada ○ 10 dedicated technical sales professionals ○ 4 Product/Application Experts ○ 7 Sales Reps via partner companies (commission only) ○ 4 sales profession als and growing in Europe International (e.g., Japan, India) ○ 45+ dealers ○ Dealers sell co mplem
Slide 7: Cap Table and Financial Metrics (C$)
Nanalysis Scientific Corp. Cap Table and Financial Metrics (C$) SHARE PRICE $0.15 (April 2026) COMMON SHARES OUTSTANDING 135MM (approximate) EBIDTA (adjusted 2025) $900,000 Sean Krakiwsky Heather Kury Julien Muller Marc Tomlinson Revenue (2025) $40MM CEO & Founder CFO CTO EVP, Services ● BSc & MSc,
Slide 8: Senior Independent Board of Directors
Senior Independent Board of Directors CHAIR OF THE BOARD Jonathan Ladd Werner Maas Mr. Ladd is an experienced technology executive Dr . Maas is a senior executive in the analytical and former CEO of NovAtel Inc., a Nasdaq -listed instrumentation sector, having previously served as GPS technology com
Slide 9: Magnetic Resonance Techniques: MRI & NMR
Magnetic Resonance Techniques: MRI & NMR share same fundamental math & physics INCUMBENT/OLD: N EW: High -Field, Superconducting Magnetic Resonance Gold Standard of Analysis & Imaging • Expensive • Affordable • Liquid Helium • No cryogens • Unsafe • Easy to use • Gatekeeper • Point of need HF • Huge
Slide 10: Proprietary Products & Services
Proprietary Products & Services Benchtop High Field NMR MRI 60 MHz 100 MHz 300 -600 MHz MRI Console FAMILY US $45K -70K US $125K -155K US $400K -$2MM US $45K via Quad Systems partner R&D labs, QA/QC Superior performance Up -market, USPs, and innovative High -performance, affordable, alternative to i
Slide 11: Intellectual Property & Manufacturing
Intellectual Property & Manufacturing Patents on main technical challenges of miniaturizing & high throughput NMR ○ Over 10 Patents granted/pending in United States, and other jurisdictions such as China and Japan ○ Patents protect k ey barriers to main technical challenge of compact NMR system deve
Slide 12: Appification Software: Key Growth Driver
Appification Software: Key Growth Driver Traditional MR Interpretation Automated MR Interpretation with AI + Cloud Complex , information rich, requires an expert ✓ Uses application -specific MR output and compares with databases, to interpret and looks like this: ML, AI computer software analysis et
Slide 13: Milestone & Catalysts
Milestone & Catalysts Founding 2009/ Pre - 2010 2011 Initial 2012 Sales &2014 2013 2015 Prove 2016 out2017 initial 2018 2019 Acquisitions 2020 Scale Business 2009 Revenue Manufacturing 2016 growth 2025 2020 2022 2024 2025 -7 ✓ Acquisition of KPrime , sales & service ✓ Partnering deals o Graduating t
Slide 14: Service is Major Part of Revenue
Service is Major Part of Revenue Products Service In the future, revenue is projected to be 50% products, 50% services. Synergistically Working together: Will lead with Service in some verticals, like Security
Slide 15: CATSA Services Contract Highlight
CATSA Services Contract Highlight • Contract signed with Canadian Air Transport Security Authority (CATSA) on May 25, 2022 • First term ends in June 2028 • Two 5 -year potential renewal terms • Servicing imaging and detection equipment in all Canadian airports. Delivering airport modernization at al
Slide 16: Independent Analysts Research Reports on NSCI
Independent Analysts Research Reports on NSCI Rob Goff at Ventum Financial: Price target of $0.75 Robert.Goff@ventumfinancial.com Doug Loe at Leede Financial: Price target of $0.93 dloe@leede.ca
Slide 17: Investment Highlights
Investment Highlights Leading Edge EBITDA + ive Technology Company Proprietary Manufacturing Growth Story All IP developed in -house, is patent Proprietary domestic manufacturing allows Nanalysis is a rapidly growing business with line -of- protected, and innovation is ongoing. We company to control
Slide 18: Thank you!
Thank you! Investor Relations Contact Jake Bouma jboumaconsulting@gmail.com +1.604.317.3936
Nanalysis Scientific — Investor Presentation (May 2026) on 6ix